Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 2
2016 3
2017 4
2019 3
2020 1
2021 5
2022 7
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, Gümüş M, Mar N, Loriot Y, Fléchon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS; EV-302 Trial Investigators. Powles T, et al. N Engl J Med. 2024 Mar 7;390(10):875-888. doi: 10.1056/NEJMoa2312117. N Engl J Med. 2024. PMID: 38446675 Clinical Trial.
Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors.
Yakobson A, Rouvinov K, Cohen AY, Goldstein I, Abu Saleh O, Solomon A, Dudnik Y, Shalata W. Yakobson A, et al. Among authors: rouvinov k. J Pers Med. 2023 Aug 30;13(9):1340. doi: 10.3390/jpm13091340. J Pers Med. 2023. PMID: 37763109 Free PMC article.
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.
Keizman D, Frenkel M, Peer A, Rosenbaum E, Sarid D, Leibovitch I, Mano R, Yossepowitch O, Wolf I, Geva R, Margel D, Rouvinov K, Stern A, Dresler H, Kushnir I, Eliaz I. Keizman D, et al. Among authors: rouvinov k. Nutrients. 2023 Aug 11;15(16):3533. doi: 10.3390/nu15163533. Nutrients. 2023. PMID: 37630724 Free PMC article. Clinical Trial.
Unexpected Adverse Events of Immune Checkpoint Inhibitors.
Shalata W, Yakobson A, Cohen AY, Goldstein I, Saleh OA, Dudnik Y, Rouvinov K. Shalata W, et al. Among authors: rouvinov k. Life (Basel). 2023 Jul 29;13(8):1657. doi: 10.3390/life13081657. Life (Basel). 2023. PMID: 37629514 Free PMC article.
Radiotherapy-Induced Atrial Myxoma: A Case Report and Literature Review.
Shalata W, Massalha I, Ishay SY, Chernomordikova E, Jama AA, Rouvinov K, Dudnik Y, Yakobson A. Shalata W, et al. Among authors: rouvinov k. Life (Basel). 2023 Jul 19;13(7):1585. doi: 10.3390/life13071585. Life (Basel). 2023. PMID: 37511961 Free PMC article.
Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis.
Rouvinov K, Levanon E, Peer A, Sarfaty M, Sarid D, Neiman V, Grikshtas E, Rosenbaum E, Kushnir I, Talmor B, Friger M, Zarbiv Y, Gez E, Dresler H, Shalata W, Meirovitz A, Shrem NS, Yakobson A, Mermershtain W, Keizman D. Rouvinov K, et al. Front Oncol. 2023 May 24;13:1151701. doi: 10.3389/fonc.2023.1151701. eCollection 2023. Front Oncol. 2023. PMID: 37293597 Free PMC article.
Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer.
Kaufman B, Abramov O, Ievko A, Apple D, Shlapobersky M, Allon I, Greenshpan Y, Bhattachrya B, Cohen O, Charkovsky T, Gayster A, Shaco-Levy R, Rouvinov K, Livoff A, Elkabets M, Porgador A. Kaufman B, et al. Among authors: rouvinov k. Sci Adv. 2023 May 26;9(21):eadg2809. doi: 10.1126/sciadv.adg2809. Epub 2023 May 26. Sci Adv. 2023. PMID: 37235664 Free PMC article.
40 results